Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionWealthfront Advisers Llc
Latest Disclosed Ownership90,562 shares
Latest Disclosed Value $ 31,864,240
Wealthfront Advisers Llc reports 10.06% increase in ownership of AMGN / Amgen Inc.

On May 5, 2026 - Wealthfront Advisers Llc filed a 13F-HR form disclosing ownership of 90,562 shares of Amgen Inc. (MX:AMGN) valued at $31,864,240 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 82,287 shares of Amgen Inc.. This represents a change in shares of 10.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COM 031162100 90,562 8,275 10.06 31,864 18.31 0.0699
2026-01-30 2025-12-31 13F AMGEN COM 031162100 82,287 12,054 17.16 26,933 35.89 0.0602
2025-11-06 2025-09-30 13F AMGEN COM 031162100 70,233 12,857 22.41 19,820 23.72 0.0465
2025-07-31 2025-06-30 13F AMGEN COM 031162100 57,376 -8,689 -13.15 16,020 -22.17 0.0413
2025-05-02 2025-03-31 13F AMGEN COM 031162100 66,065 15,521 30.71 20,583 56.24 0.0553
2025-04-01 2024-12-31 13F/A-1 AMGEN COM 031162100 50,544 -2,565 -4.83 13,174 -23.02 0.0385
2024-11-12 2024-09-30 13F AMGEN COM 031162100 53,109 -393 -0.73 17,112 2.37 0.0526
2024-08-14 2024-06-30 13F AMGEN COM 031162100 53,502 2,883 5.70 16,717 16.16 0.0562
2024-04-19 2024-03-31 13F AMGEN COM 031162100 50,619 -1,163 -2.25 14,392 -3.51 0.0504
2024-02-09 2023-12-31 13F AMGEN COM 031162100 51,782 -1,170 -2.21 14,914 4.80 0.0573
2023-11-01 2023-09-30 13F AMGEN COM 031162100 52,952 -3,295 -5.86 14,231 13.97 0.0613
2023-08-07 2023-06-30 13F AMGEN COM 031162100 56,247 -8,060 -12.53 12,488 -19.68 0.0530
2023-04-28 2023-03-31 13F AMGEN COM 031162100 64,307 -1,557 -2.36 15,546 -10.13 0.0706
2023-02-10 2022-12-31 13F AMGEN COM 031162100 65,864 8,993 15.81 17,299 34.94 0.0838
2022-11-14 2022-09-30 13F AMGEN COM 031162100 56,871 10,768 23.36 12,819 14.28 0.0682
2022-07-20 2022-06-30 13F AMGEN COM 031162100 46,103 13,473 41.29 11,217 42.17 0.0564
2022-05-16 2022-03-31 13F AMGEN COM 031162100 32,630 7,691 30.84 7,890 40.64 0.0346
2022-01-21 2021-12-31 13F AMGEN COM 031162100 24,939 -4,079 -14.06 5,610 -9.09 0.0237
2021-11-15 2021-09-30 13F AMGEN COM 031162100 29,018 -4,814 -14.23 6,171 -25.17 0.0286
2021-08-16 2021-06-30 13F AMGEN COM 031162100 33,832 -850 -2.45 8,247 -4.43 0.0392
2021-05-14 2021-03-31 13F AMGEN COM 031162100 34,682 3,805 12.32 8,629 21.55 0.0462
2021-02-16 2020-12-31 13F AMGEN COM 031162100 30,877 -2,395 -7.20 7,099 -16.05 0.0427
2020-11-16 2020-09-30 13F AMGEN COM 031162100 33,272 -8 -0.02 8,456 7.73 0.0604
2020-08-14 2020-06-30 13F AMGEN COM 031162100 33,280 2,147 6.90 7,849 24.35 0.0609
2020-05-15 2020-03-31 13F AMGEN COM 031162100 31,133 8,474 37.40 6,312 15.56 0.0573
2020-01-21 2019-12-31 13F AMGEN COM 031162100 22,659 1,637 7.79 5,462 34.27 0.0405
2019-10-15 2019-09-30 13F AMGEN COM 031162100 21,022 2,108 11.15 4,068 16.73 0.0341
2019-08-13 2019-06-30 13F AMGEN COM 031162100 18,914 -1,334 -6.59 3,485 -9.41 0.0303
2019-05-13 2019-03-31 13F AMGEN COM 031162100 20,248 -9,965 -32.98 3,847 -34.60 0.0357
2019-02-14 2018-12-31 13F AMGEN COM 031162100 30,213 30,213 5,882 0.0625
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.